Asymmetric bifunctional silyl monomers and particles thereof as prodrugs and delivery vehicles for pharmaceutical, chemical and biological agents
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-047/48
B82Y-005/00
C07F-007/08
C07F-007/18
C07H-023/00
C07K-019/00
C12N-015/113
A61K-047/60
A61K-047/58
A61K-047/61
A61K-047/62
A61K-047/69
출원번호
US-0283574
(2016-10-03)
등록번호
US-9913916
(2018-03-13)
발명자
/ 주소
DeSimone, Joseph M.
Finniss, Mathew
Napier, Mary
Pandya, Ashish
Parrott, Matthew
출원인 / 주소
The University of North Carolina at Chapel Hill
대리인 / 주소
Alston & Bird LLP
인용정보
피인용 횟수 :
0인용 특허 :
6
초록▼
Asymmetric bifunctional silyl (ABS) monomers comprising covalently linked pharmaceutical, chemical and biological agents are described. These agents can also be covalently bound via the silyl group to delivery vehicles for delivering the agents to desired targets or areas. Also described are deliver
Asymmetric bifunctional silyl (ABS) monomers comprising covalently linked pharmaceutical, chemical and biological agents are described. These agents can also be covalently bound via the silyl group to delivery vehicles for delivering the agents to desired targets or areas. Also described are delivery vehicles which contain ABS monomers comprising covalently linked agents and to vehicles that are covalently linked to the ABS monomers. The silyl modifications described herein can modify properties of the agents and vehicles, thereby providing desired solubility, stability, hydrophobicity and targeting.
대표청구항▼
1. A method for making a particle comprising: a. first, covalently linking a monomer and a silyl via an O, N, S, or carboxyl of said monomer to form a silyl functionalized monomer;b. second, covalently linking a nucleic acid to said silyl functionalized monomer to form a first nucleic acid-silyl fun
1. A method for making a particle comprising: a. first, covalently linking a monomer and a silyl via an O, N, S, or carboxyl of said monomer to form a silyl functionalized monomer;b. second, covalently linking a nucleic acid to said silyl functionalized monomer to form a first nucleic acid-silyl functionalized monomer; andc. third, forming a particle from the first nucleic acid-silyl functionalized monomer of step b,wherein the nucleic acid-silyl functionalized monomer has the structure: wherein R1′and R2′are independently alkyl;wherein M is a monomer selected from the group consisting of 2-hydroxyethyl acrylate, 2-hydroxyethyl methacrylate , vinyl pyrrolidone, acrylic acid, ethylene oxide, poly(ethylene oxide), vinyl alcohol, a protein, an amino acid, and a polysaccharide;wherein Xa and Xb are independently selected from the group consisting of O, NH, S, and a carboxyl; andwherein R3′is a nucleic acid. 2. The method of claim 1, wherein forming the particle comprises molding the first nucleic acid-silyl functionalized monomer in a mold cavity. 3. The method of claim 1, wherein forming the particle further comprises associating a biocompatible polymer with the first nucleic acid-silyl functionalized monomer through a covalent link, physical entanglement, electrostatic association or hydrostatic association. 4. The method of claim 1, further comprising a second nucleic acid-silyl functionalized monomer. 5. The method of claim 4, wherein the second nucleic acid-silyl functionalized monomer comprises the same or different monomer or nucleic acid as the first nucleic acid-silyl functionalized monomer. 6. The method of claim 1, wherein the nucleic acid comprises a ratio of 0.1 mg of nucleic acid to 1 mg of particle. 7. The method of claim 1, wherein the nucleic acid-silyl functionalized monomer comprises between 1 wt % and 50 wt % of the particle. 8. The method of claim 1, wherein the nucleic acid-silyl functionalized monomer comprises between 1 wt % and 40 wt % of of the particle. 9. The method of claim 1, wherein the nucleic acid-silyl functionalized monomer comprises between 2 wt % and 20 wt % of the particle. 10. The method of claim 4, wherein forming the particle comprises molding the nucleic acid-silyl functionalized monomers in a mold cavity. 11. The method of claim 1, wherein the nucleic acid is selected from the group consisting of RNA, siRNA, DNA, and combinations thereof. 12. The method of claim 1, wherein Xa and Xb are both O. 13. The method of claim 1, wherein R1′and R2′are independently selected from the group consisting of methyl, ethyl, n-propyl, iso-propyl, n-butyl, sec-butyl, iso-butyl, and tert-butyl. 14. The method of claim 1, wherein the particle has a release rate of approximately 4 times slower at pH 7.4 relative to a release rate at pH 5.0. 15. The method of claim 1, wherein the particle has a release rate of approximately 50.4 times slower at pH 5.0 and 201 times slower at pH 7.4 relative to a release rate at pH 5.0 wherein R1′and R2′are ethyl.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (6)
Liles Donald Taylor, .beta.-diketo functional organosilicon compounds.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.